ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Profession
Setting [clear]
Client Age
Topic Area
Experience
Course Format
SIG [clear]
Instructional Level [clear]
Results 11 - 14 of 14
Credit(s): PDHs: 5.5, ASHA CEUs*: 0.55
Summary: In this SIG 4 activity, authors explore ways to provide experiential learning to graduate students enrolled in stuttering courses (Palasik, Hughes, & Ellis) and discuss the clinical experiences of school-based speech-language pathologists related to stuttering (Panico, Daniels, Yarzebinski, & Hughes), strategies for teachers to support children who stutter (Cozart & Wilson), and ways to interrupt the narrative of ableism that surrounds the treatment of stuttering (Gerlach-Houck & Constantino). Each of these articles provides a unique perspective on ways that professionals can seek to create a more supportive environment for our clients who stutter by changing the foundations of the way we teach preservice clinicians, support our school-based colleagues, and address the narrative of ableism that pervades our culture.
Credit(s): PDHs: 4.5, ASHA CEUs*: 0.45
Summary: The theme for this SIG 14 activity is examining challenges for faculty and students in communication sciences and disorders (CSD). Topics include (a) challenges faced by academic mothers in CSD programs; (b) challenges faced by faculty of color in CSD departments; and (c) examining microaggression endorsement in CSD students.
Credit(s): PDHs: 3.0, ASHA CEUs*: 0.3
Summary: The theme for this SIG 14 activity is clinical considerations through paradigm shifts in providing culturally relevant family-centered intervention and instruction. Topics include (a) providing culturally relevant family centered care; (b) second language literacy instruction for multilingual adolescents; and (c) impacts of study abroad experiences on students’ intercultural competence.
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: The article in this SIG 6 activity focuses on the audiologic variations seen among patients undergoing the same type of ototoxic drug treatment (cisplatin). Results show a large amount of audiologic outcome variability among the two patients examined, despite similar demographic factors, drug treatments, and types of cancer. Factors relating to ototoxic susceptibility are discussed, and the importance of otoxicity monitoring programs for early detection of audiologic change is highlighted.
<< 1 2 > >>